GPT and anemia: The most commonly observed blood variables’ abnormalities before treatment were grade 1 or 2 anemia in 54% of patients, grade 1 eGFR reduction in 46% of patients, elevated Cr level in 8% of patients, and minimal hepatic injury with increased ALP, AST, and ALT in 25%, 6%, and 4% patients, respectively.